ZUBQUSAS Trademark

Trademark Overview

On Tuesday, October 28, 2025, a trademark application was filed for ZUBQUSAS with the United States Patent and Trademark Office. The USPTO has given the ZUBQUSAS trademark a serial number of 99465733. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 4, 2026. This trademark is owned by Pfizer Inc.. The ZUBQUSAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Vaccines for human use
zubqusas

General Information

Serial Number99465733
Word MarkZUBQUSAS
Filing DateTuesday, October 28, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Trademark Events

Event DateEvent Description
Tuesday, October 28, 2025NEW APPLICATION ENTERED
Tuesday, October 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 10, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 4, 2026ASSIGNED TO EXAMINER
Wednesday, February 4, 2026NON-FINAL ACTION WRITTEN
Wednesday, February 4, 2026NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

zubqusas disorders preparations treatment pharmaceutical migraine pain stroke hypertension obesity skin